A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy, a currently incurable disease that is the leading genetic cause of death in infants. The new molecule fixes a mistake in a cellular processing mec ...
Source:
Cold Spring Harbor Laboratory
Wednesday, November 4, 2009